They developed antibodies to a greater or lesser extent. Next steps will be to determine whether those antibodies confer immunity and how much (the Oxford vaccine that was the frontrunner may have mitigated symptoms in Rhesus monkeys but didn't confer immunity- back to the drawing board). Then a question of human safety. It will be a tough call to decide how far to rush that step. If anything even gets that far I assume we'll have a form of human trials where the first doses are given to volunteers around hot spots, which would be unprecedented. That would take an additional several months to evaluate.
Being an anti-vaxxer, BA, you'll have to decide on that one and its another possible problem- the anti-vax movement is pushing hard against it.
Although I don't think this one has any Gates money behind it so may not be a plot to brain chip the population or place the mark of the beast on them. I'm not making those things up- they're out there in relatively viral form.
